Dr. Yun Huang's lab at Texas A&M University focuses on understanding how epigenetic factors regulate heart development. The team investigates how specific genetic mutations and maternal diet can impact heart formation and contribute to congenital heart diseases. They use cutting-edge techniques with genetically modified mouse models and human stem cells to explore these mechanisms and seek ways to improve heart development and health.

Dr. Roderick H. Dashwood's lab focuses on cancer research, specifically targeting immune responses in patients with Familial Adenomatous Polyposis (FAP), a genetic condition that increases the risk of colorectal cancer. The lab investigates how certain drugs can upregulate the Major Histocompatibility Complex (MHC) on cancer cells to enhance the immune system's ability to recognize and attack tumors. By combining traditional cancer drugs with new epigenetic therapies, they aim to improve immune responses before cancer develops, thereby offering new interventions for at-risk patients.